Target intelligence / Profile preview

Sarcoptes scabiei (human itch mite)

Molecular classification
Other (Ectoparasite, Arthropod, Mite)
01

Overview

Sarcoptes scabiei is a microscopic ectoparasitic mite responsible for human scabies. The female mite burrows into the stratum corneum of human skin where she lays eggs; this process triggers intense itching due to a hypersensitivity reaction. The life cycle includes egg, larva, nymph, and adult stages entirely within the host’s epidermis. Scabies spreads primarily through prolonged direct skin-to-skin contact but can also be transmitted by contaminated clothing or bedding. Crusted (“Norwegian”) scabies represents a severe form with massive numbers of mites seen especially in immunocompromised individuals; it is highly contagious and difficult to treat due to thick crusts protecting mites from topical therapies[1][2][3][4][5]. **Note:** The entry "Scabies mite and other ectoparasites causing cutaneous infestation/scabies etc." is not a canonical molecular target but rather refers collectively to parasitic organisms—primarily Sarcoptes scabiei—that cause cutaneous infestations like scabies. It does not represent a single molecule/receptor/enzyme/transporter suitable for drug targeting classification; instead it describes an organismal pathogen group[2].

Other names
Scabies miteHuman itch miteSarcoptes scabiei var. hominis
02

Mechanism of action

Permethrin and other topical agents act as neurotoxins to the mites, disrupting sodium channel function and causing paralysis and death. Ivermectin is an oral antiparasitic that binds to glutamate-gated chloride channels in the nerve and muscle cells of the parasite, leading to paralysis and death[4][5].

03

Biological functions

Parasitic infestation of skinEgg laying in epidermisInduction of host immune response (allergic reaction)Transmission between hosts via skin contact
04

Disease associations

Infection (cutaneous infestation)Other (Neglected Tropical Disease)
05

Safety considerations

Treatment challenges include reinfestation from untreated contacts or fomites, resistance to some topical agents in certain regions, difficulty eradicating crusted scabies due to high mite burden and protective crusts on skin[1][5].Secondary bacterial infections can lead to severe complications such as sepsis or post-streptococcal glomerulonephritis[4].
06

Interacting drugs

Permethrin

3 more in the full profile.

Beyond the preview

Go deeper on Sarcoptes scabiei (human itch mite).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sarcoptes scabiei (human itch mite).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call